BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bernhard N, Lepper PM, Vogelmeier C, Seibert M, Wagenpfeil S, Bals R, Fähndrich S. Deterioration of quality of life is associated with the exacerbation frequency in individuals with alpha-1-antitrypsin deficiency - analysis from the German Registry. Int J Chron Obstruct Pulmon Dis 2017;12:1427-37. [PMID: 28553095 DOI: 10.2147/COPD.S130925] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
Number Citing Articles
1 Rangaraju M, Turner AM. Why is Disease Penetration so Variable in Alpha-1 Antitrypsin Deficiency? The Contribution of Environmental Factors. Chronic Obstr Pulm Dis 2020;7:280-9. [PMID: 32698254 DOI: 10.15326/jcopdf.7.3.2019.0177] [Reference Citation Analysis]
2 Miravitlles M, Herepath M, Priyendu A, Sharma S, Vilchez T, Vit O, Haensel M, Lepage V, Gens H, Greulich T. Disease burden associated with alpha-1 antitrypsin deficiency: systematic and structured literature reviews. Eur Respir Rev 2022;31:210262. [PMID: 35321931 DOI: 10.1183/16000617.0262-2021] [Reference Citation Analysis]
3 Stockley RA, Edgar RG, Starkey S, Turner AM. Health status decline in α-1 antitrypsin deficiency: a feasible outcome for disease modifying therapies? Respir Res 2018;19:137. [PMID: 30029692 DOI: 10.1186/s12931-018-0844-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
4 Smith DJ, Ellis PR, Turner AM. Exacerbations of Lung Disease in Alpha-1 Antitrypsin Deficiency. Chronic Obstr Pulm Dis 2021;8. [PMID: 33238089 DOI: 10.15326/jcopdf.2020.0173] [Reference Citation Analysis]